None listed
Conditions
Interventions
Drug, Biological/Vaccine : Among patients who diagnosed osteoarthrititis inject Hyaluronic acid(Hyal Forte) and PRP in glenoid cavity respectively and expected to comparison the results. Hyaluronic ac
Sponsors
Eulji University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Patient who treated for primary degenerative osteoarthritis ? kellgren Lawrence Gr 1 to 3 in radiograph patients with who complaining of pain in the knee joint over 3 months before research and has no effect or can’t use for side effect on NSAIDs
Exclusion criteria
Exclusion criteria: ? Patient who is not a primary degenerative arthritis same as rheumarthritis or traumatic arthritis. ? patient who is primary degenerative arthritis with Kellgren Lawrence Gr4 ? be suspected of knee joint pain by meniscus injury ? In case of intra articular injection within 3 months ? In case of Diabetes, inflammation, malignant tumor ? In case of coagulopathy or being treated by anticoagulants ? In case of hemoglobin level is under 11 or platelet level is under 15 ? In case of variation of knee joint varus/vargus more than 5 degree ? had previously surgery around knee joint area such as ligament surgery or high tibial osteotomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain (Using questionnaire) | — |
Secondary
| Measure | Time frame |
|---|---|
| discomfort (Using questionnaire);symptom (Using questionnaire);degree of activity (Using questionnaire) | — |
Countries
Korea, Republic of
Contacts
Public ContactSe-hyun Jung
Eulji University Hospital
Outcome results
None listed